Elicio Therapeutics, Inc. (ELTX) Debt by Year
Elicio Therapeutics, Inc. carried $9.4M in long-term debt against $18.6M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 53.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Elicio Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ELTX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ELTX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $9.5M+2.1% | $9.5M | $9.4M-53.0% | $9.7M | $9.3M | N/A | $20.0M | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $23.5M+6.3% | $14.9M-18.5% | $18.6M+5.4% | $20.6M-20.8% | $22.1M+544.9% | $18.4M+54.8% | $17.6M+36.6% | $26.0M+75.3% | $3.4M-84.2% | $11.9M+38.3% | $12.9M+109.5% | $14.8M+707.0% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Elicio Therapeutics, Inc. financials
Frequently Asked Questions
What was Elicio Therapeutics, Inc.'s long-term debt in fiscal year 2025?
Elicio Therapeutics, Inc. carried $9.4M in long-term debt against $18.6M in cash and equivalents at the end of fiscal year 2025.
How fast is Elicio Therapeutics, Inc.'s long-term debt growing?
Elicio Therapeutics, Inc. (ELTX) long-term debt fell by 53.0% year over year, from $20.0M to $9.4M in fiscal year 2025.
How has Elicio Therapeutics, Inc.'s long-term debt changed over the years?
Across the 6 fiscal years this page covers, Elicio Therapeutics, Inc. (ELTX) long-term debt went from $635K in fiscal year 2020 to $9.4M in fiscal year 2025.
What was Elicio Therapeutics, Inc.'s long-term debt in the most recent quarter?
Elicio Therapeutics, Inc. (ELTX) reported $9.5M in long-term debt in Q2 2026. This represents an increase of 2.1% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Elicio Therapeutics, Inc. (ELTX) reported on that line in every period on record.